Walleye Capital LLC Sarepta Therapeutics, Inc. Put Options Transaction History

Walleye Capital LLC

  • $46.2 Billion
  • Q3 2024

Put Options

12 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$124.33 - $156.75 $1.8 Million - $2.27 Million
14,500 Added 725.0%
16,500 $2.06 Million
Q2 2024

Aug 14, 2024
SELL
$113.33 - $163.85 $419,321 - $606,245
-3,700 Reduced 64.91%
2,000 $316,000
Q1 2024

May 15, 2024
SELL
$93.7 - $141.53 $1.05 Million - $1.59 Million
-11,200 Reduced 66.27%
5,700 $737,000
Q4 2023

Feb 14, 2024
BUY
$67.31 - $124.76 $753,872 - $1.4 Million
11,200 Added 196.49%
16,900 $1.63 Million
Q3 2023

Nov 14, 2023
SELL
$102.5 - $123.59 $338,250 - $407,847
-3,300 Reduced 36.67%
5,700 $690,000
Q2 2023

Aug 14, 2023
SELL
$106.4 - $157.19 $255,360 - $377,256
-2,400 Reduced 21.05%
9,000 $1.03 Million
Q1 2023

May 15, 2023
BUY
$117.53 - $155.99 $975,499 - $1.29 Million
8,300 Added 267.74%
11,400 $1.57 Million
Q4 2022

Feb 14, 2023
SELL
$100.86 - $132.13 $262,236 - $343,538
-2,600 Reduced 45.61%
3,100 $401,000
Q3 2022

Nov 14, 2022
BUY
$75.71 - $119.24 $431,546 - $679,668
5,700 New
5,700 $630,000
Q1 2020

May 15, 2020
SELL
$82.38 - $131.64 $634,326 - $1.01 Million
-7,700 Closed
0 $0
Q4 2019

Feb 14, 2020
BUY
$76.53 - $135.58 $482,139 - $854,154
6,300 Added 450.0%
7,700 $994,000
Q3 2019

Nov 14, 2019
BUY
$72.81 - $156.91 $101,934 - $219,674
1,400 New
1,400 $105,000

Others Institutions Holding SRPT

# of Institutions
529
Shares Held
83.9M
Call Options Held
2.06M
Put Options Held
1.52M
View Full List

About Sarepta Therapeutics, Inc.

SRPT Quotes by TradingView
  • Ticker SRPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,567,904
  • Market Cap $10.2B
  • Description
  • Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...
More about SRPT
Track This Portfolio

Track Walleye Capital LLC Portfolio

Follow Walleye Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Capital LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email